PTPN2 and cancer: We have recently shown that loss of PTPN2 in myeloid cells results in increased susceptibility to experimental colitis, while protecting from colitis-associated cancer in an inflammasome-dependent manner,17 but the molecular consequences of PTPN2 deletion in myeloid cells, and especially in macrophages, are still not well understood.